Claudia Lin, Ph.D. has been named general manager of Alphamab (Jiangsu) Biopharmaceuticals Co., Ltd., a newly established subsidiary to manufacture and develop multiple novel biologics in the Alphamab pipeline. Additionally, Mike Liu, Ph.D., was appointed executive vice president to lead global business development.   Dr. Lin previously served as vice president at Innovent Biologics, responsible for GMP compliance and Quality management. Prior to Innovent, Dr. Lin served as head of Quality Ass...